XML 30 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1
DERIVATIVE FINANCIAL INSTRUMENTS
6 Months Ended
Dec. 30, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
DERIVATIVE FINANCIAL INSTRUMENTS
Derivative Financial Instruments
As of December 30, 2017, the Company had outstanding foreign currency forward contracts and swaps with a total notional amount of $51.3 million. The maturity dates for these contracts and swaps extend through December 2019. For the three months ended December 30, 2017, the Company entered into $7.2 million of foreign currency forward contracts and settled $11.2 million of such contracts. During the same period of the previous year, the Company entered into $6.7 million of foreign currency forward contracts and settled $5.0 million of such contracts.
For the six months ended December 30, 2017, the Company entered into foreign currency forward contracts of $7.2 million and settled $16.6 million of such contracts. During the same period of the previous year, the Company entered into foreign currency forward contracts of $6.7 million and settled $10.2 million of such contracts.
As of December 30, 2017, the aggregate notional amount of the Company’s outstanding foreign currency contracts and swaps along with their unrealized gains (losses) are expected to mature as summarized below (in thousands):
Quarter Ending
 
Notional Contracts and Swaps in MXN
 
Notional Contracts and Swaps in USD
 
Estimated Fair Value
March 31, 2018
 
$
90,812

 
$
5,713

 
$
(1,120
)
June 30, 2018
 
$
95,500

 
$
5,811

 
$
(1,055
)
September 29, 2018
 
$
90,443

 
$
5,301

 
$
(867
)
December 29, 2018
 
$
125,328

 
$
6,746

 
$
(703
)
March 30, 2019
 
$
137,944

 
$
6,979

 
$
(433
)
June 29, 2019
 
$
142,947

 
$
6,828

 
$
(152
)
September 28, 2019
 
$
148,468

 
$
6,740

 
$
86

December 28, 2019
 
$
152,613

 
$
7,187

 
$
(259
)

On October 1, 2014, the Company entered into an interest rate swap contract with an effective date of September 1, 2015 and a termination date of September 3, 2019, with a notional amount of $25.0 million related to the borrowings outstanding under the term loan. This interest rate swap pays the Company variable interest at the one month LIBOR rate, and the Company pays the counter party a fixed interest rate. The fixed interest rate for the contract is 1.97% that replaces the one month LIBOR rate component of our contractual interest to be paid to WFB as part of our term loan. Based on the terms of the interest rate swap contract and the underlying borrowings outstanding under the term loan, the interest rate contract was determined to be effective, and thus qualifies as a cash flow hedge.
The following table summarizes the fair value of derivative instruments in the Consolidated Balance Sheet as of December 30, 2017 and July 1, 2017 (in thousands):
 
 
 
December 30, 2017
 
July 1, 2017
Derivatives Designated as Hedging Instruments
Balance Sheet Location
 
Fair Value
 
Fair Value
Foreign currency forward contracts & swaps
Other long-term assets
 
$
86

 
$
1,010

Foreign currency forward contracts & swaps
Other current liabilities
 
$
(3,745
)
 
$
(4,226
)
Foreign currency forward contracts & swaps
Other long-term liabilities
 
$
(844
)
 
$
(886
)
Interest rate swap
Other long-term assets
 
$
3

 
$

Interest rate swap
Other current liabilities
 
$
(27
)
 
$
(81
)
Interest rate swap
Other long-term liabilities
 
$

 
$
(22
)


The following tables summarize the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the three months ended December 30, 2017 and December 31, 2016, respectively (in thousands):
Derivatives Designated as Hedging Instruments
Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
 
AOCI Balance
as of
September 30, 2017
 
Effective
Portion
Recorded In
AOCI
 
Effective Portion
Reclassified From
AOCI Into
Income
 
AOCI Balance
as of
December 30, 2017
Forward contracts & swaps
Cost of sales
 
$
(1,715
)
 
$
(2,669
)
 
$
1,412

 
$
(2,972
)
Interest rate swap
Interest expense
 
(48
)
 
8

 
24

 
(16
)
Total
 
 
$
(1,763
)
 
$
(2,661
)
 
$
1,436

 
$
(2,988
)
 
 
 
 
 
 
 
 
 
 
Derivatives Designated as Hedging Instruments
Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
 
AOCI Balance
as of
October 1, 2016
 
Effective
Portion
Recorded In
AOCI
 
Effective Portion
Reclassified From
AOCI Into
Income
 
AOCI Balance
as of
December 31, 2016
Forward contracts & swaps
Cost of sales
 
$
(8,325
)
 
$
(2,717
)
 
$
1,341

 
$
(9,701
)
Interest rate swap
Interest expense
 
(248
)
 
42

 
68

 
(138
)
Total
 
 
$
(8,573
)
 
$
(2,675
)
 
$
1,409

 
$
(9,839
)

The following tables summarize the gain (loss) on derivative instruments, net of tax, on the Consolidated Statements of Income for the six months ended December 30, 2017 and December 31, 2016, respectively (in thousands):
Derivatives Designated as Hedging Instruments
Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
 
AOCI Balance
as of
July 1, 2017
 
Effective
Portion
Recorded In
AOCI
 
Effective Portion
Reclassified From
AOCI Into
Income
 
AOCI Balance
as of
December 30, 2017
Forward contracts & swaps
Cost of sales
 
$
(2,707
)
 
$
(2,791
)
 
$
2,526

 
$
(2,972
)
Interest rate swap
Interest expense
 
(68
)
 
(1
)
 
53

 
(16
)
Total
 
 
$
(2,775
)
 
$
(2,792
)
 
$
2,579

 
$
(2,988
)
 
 
 
 
 
 
 
 
 
 
Derivatives Designated as Hedging Instruments
Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
 
AOCI Balance
as of
July 2, 2016
 
Effective
Portion
Recorded In
AOCI
 
Effective Portion
Reclassified From
AOCI Into
Income
 
AOCI Balance
as of
December 31, 2016
Forward contracts & swaps
Cost of sales
 
$
(7,245
)
 
$
(4,906
)
 
$
2,450

 
$
(9,701
)
Interest rate swap
Interest expense
 
(328
)
 
41

 
149

 
(138
)
Total
 
 
$
(7,573
)
 
$
(4,865
)
 
$
2,599

 
$
(9,839
)

As of December 30, 2017, the net amount of unrealized loss expected to be reclassified into earnings within the next 12 months is approximately $3.0 million. As of December 30, 2017, the Company does not have any foreign exchange contracts with credit-risk-related contingent features.